1.39
|
1.20e-22
|
GO:0009653
|
anatomical structure morphogenesis
|
1.08
|
6.38e-19
|
GO:0009987
|
cellular process
|
1.12
|
1.60e-18
|
GO:0065007
|
biological regulation
|
1.20
|
1.02e-17
|
GO:0032502
|
developmental process
|
1.13
|
1.29e-17
|
GO:0050794
|
regulation of cellular process
|
1.21
|
3.15e-17
|
GO:0007275
|
multicellular organismal development
|
1.12
|
5.36e-17
|
GO:0050789
|
regulation of biological process
|
1.26
|
5.75e-17
|
GO:0048522
|
positive regulation of cellular process
|
1.24
|
8.72e-17
|
GO:0048731
|
system development
|
1.22
|
1.75e-16
|
GO:0048856
|
anatomical structure development
|
1.33
|
5.94e-16
|
GO:0007399
|
nervous system development
|
1.24
|
7.25e-16
|
GO:0048518
|
positive regulation of biological process
|
1.42
|
1.54e-14
|
GO:0022008
|
neurogenesis
|
1.57
|
1.61e-14
|
GO:0000904
|
cell morphogenesis involved in differentiation
|
1.50
|
1.61e-14
|
GO:0032989
|
cellular component morphogenesis
|
1.27
|
2.13e-14
|
GO:0030154
|
cell differentiation
|
1.26
|
8.25e-14
|
GO:0048869
|
cellular developmental process
|
1.46
|
2.42e-13
|
GO:0030182
|
neuron differentiation
|
1.40
|
2.88e-13
|
GO:0048468
|
cell development
|
1.50
|
3.42e-13
|
GO:0000902
|
cell morphogenesis
|
1.40
|
1.69e-12
|
GO:0048699
|
generation of neurons
|
1.52
|
8.64e-12
|
GO:0031175
|
neuron projection development
|
1.17
|
1.32e-11
|
GO:0031323
|
regulation of cellular metabolic process
|
1.23
|
2.23e-11
|
GO:0048523
|
negative regulation of cellular process
|
1.47
|
2.66e-11
|
GO:0048666
|
neuron development
|
1.54
|
3.12e-11
|
GO:0048667
|
cell morphogenesis involved in neuron differentiation
|
1.22
|
4.21e-11
|
GO:0048519
|
negative regulation of biological process
|
1.53
|
7.21e-11
|
GO:0048812
|
neuron projection morphogenesis
|
1.17
|
1.10e-10
|
GO:0080090
|
regulation of primary metabolic process
|
1.43
|
1.92e-10
|
GO:0030030
|
cell projection organization
|
1.53
|
3.06e-10
|
GO:0007409
|
axonogenesis
|
1.48
|
6.74e-10
|
GO:0048858
|
cell projection morphogenesis
|
1.17
|
7.10e-10
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.47
|
1.11e-09
|
GO:0032990
|
cell part morphogenesis
|
1.35
|
1.28e-09
|
GO:0050793
|
regulation of developmental process
|
1.13
|
2.26e-09
|
GO:0043170
|
macromolecule metabolic process
|
1.32
|
8.70e-09
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.36
|
1.12e-08
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.35
|
1.55e-08
|
GO:0051128
|
regulation of cellular component organization
|
1.15
|
1.72e-08
|
GO:0023052
|
signaling
|
1.19
|
1.99e-08
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.38
|
3.01e-08
|
GO:0009790
|
embryo development
|
1.14
|
3.27e-08
|
GO:0019222
|
regulation of metabolic process
|
1.39
|
4.23e-08
|
GO:0007167
|
enzyme linked receptor protein signaling pathway
|
1.13
|
5.84e-08
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.28
|
7.35e-08
|
GO:0031325
|
positive regulation of cellular metabolic process
|
1.35
|
7.41e-08
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.18
|
9.27e-08
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.50
|
1.28e-07
|
GO:0043009
|
chordate embryonic development
|
1.37
|
1.31e-07
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.10
|
1.32e-07
|
GO:0044238
|
primary metabolic process
|
1.17
|
1.79e-07
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.17
|
1.82e-07
|
GO:0009889
|
regulation of biosynthetic process
|
1.49
|
2.18e-07
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
1.26
|
2.24e-07
|
GO:0009893
|
positive regulation of metabolic process
|
1.38
|
2.62e-07
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
1.21
|
4.69e-07
|
GO:0048513
|
organ development
|
1.17
|
4.93e-07
|
GO:0010468
|
regulation of gene expression
|
1.32
|
5.69e-07
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
1.27
|
5.99e-07
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
1.22
|
7.40e-07
|
GO:0023051
|
regulation of signaling
|
1.35
|
8.74e-07
|
GO:0010628
|
positive regulation of gene expression
|
1.31
|
1.01e-06
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.33
|
1.11e-06
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.42
|
1.11e-06
|
GO:0072358
|
cardiovascular system development
|
1.42
|
1.11e-06
|
GO:0072359
|
circulatory system development
|
1.33
|
1.11e-06
|
GO:2000026
|
regulation of multicellular organismal development
|
1.25
|
1.42e-06
|
GO:0051239
|
regulation of multicellular organismal process
|
1.24
|
1.64e-06
|
GO:0009966
|
regulation of signal transduction
|
1.34
|
2.07e-06
|
GO:0045595
|
regulation of cell differentiation
|
1.13
|
2.15e-06
|
GO:0051716
|
cellular response to stimulus
|
1.14
|
2.24e-06
|
GO:0007165
|
signal transduction
|
1.30
|
2.45e-06
|
GO:0031324
|
negative regulation of cellular metabolic process
|
1.16
|
2.53e-06
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.36
|
3.14e-06
|
GO:0009887
|
organ morphogenesis
|
1.16
|
3.41e-06
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.08
|
5.14e-06
|
GO:0008152
|
metabolic process
|
1.54
|
6.08e-06
|
GO:0001568
|
blood vessel development
|
1.27
|
6.92e-06
|
GO:0009892
|
negative regulation of metabolic process
|
1.17
|
1.12e-05
|
GO:0051252
|
regulation of RNA metabolic process
|
1.38
|
1.16e-05
|
GO:0007169
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
1.13
|
1.19e-05
|
GO:0071840
|
cellular component organization or biogenesis
|
1.13
|
2.17e-05
|
GO:0016043
|
cellular component organization
|
1.28
|
2.31e-05
|
GO:0009888
|
tissue development
|
1.28
|
2.44e-05
|
GO:0006351
|
transcription, DNA-dependent
|
1.49
|
3.31e-05
|
GO:0001944
|
vasculature development
|
1.26
|
3.79e-05
|
GO:0032879
|
regulation of localization
|
1.09
|
4.00e-05
|
GO:0044237
|
cellular metabolic process
|
1.48
|
4.06e-05
|
GO:0048729
|
tissue morphogenesis
|
1.15
|
4.62e-05
|
GO:0071842
|
cellular component organization at cellular level
|
1.45
|
5.12e-05
|
GO:0007411
|
axon guidance
|
1.27
|
5.23e-05
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
1.15
|
8.04e-05
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.38
|
8.67e-05
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
1.18
|
1.09e-04
|
GO:0048583
|
regulation of response to stimulus
|
1.42
|
1.17e-04
|
GO:0048598
|
embryonic morphogenesis
|
1.32
|
1.25e-04
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.38
|
1.27e-04
|
GO:0051094
|
positive regulation of developmental process
|
1.30
|
1.49e-04
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.37
|
1.60e-04
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
1.30
|
1.61e-04
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.55
|
1.90e-04
|
GO:0001701
|
in utero embryonic development
|
1.29
|
1.97e-04
|
GO:0006468
|
protein phosphorylation
|
1.16
|
2.33e-04
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.31
|
2.44e-04
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.47
|
3.09e-04
|
GO:0035295
|
tube development
|
1.42
|
3.12e-04
|
GO:0007389
|
pattern specification process
|
1.50
|
4.19e-04
|
GO:0051129
|
negative regulation of cellular component organization
|
1.13
|
5.09e-04
|
GO:0019538
|
protein metabolic process
|
1.17
|
5.10e-04
|
GO:0006464
|
protein modification process
|
1.17
|
8.40e-04
|
GO:0010467
|
gene expression
|
1.25
|
1.33e-03
|
GO:0008219
|
cell death
|
1.42
|
1.54e-03
|
GO:0051130
|
positive regulation of cellular component organization
|
1.23
|
1.64e-03
|
GO:0032774
|
RNA biosynthetic process
|
1.30
|
1.98e-03
|
GO:0010629
|
negative regulation of gene expression
|
1.41
|
2.11e-03
|
GO:0022603
|
regulation of anatomical structure morphogenesis
|
1.24
|
2.41e-03
|
GO:0016265
|
death
|
1.22
|
2.84e-03
|
GO:0032268
|
regulation of cellular protein metabolic process
|
1.13
|
3.07e-03
|
GO:0009058
|
biosynthetic process
|
1.13
|
3.09e-03
|
GO:0044267
|
cellular protein metabolic process
|
1.22
|
3.44e-03
|
GO:0006793
|
phosphorus metabolic process
|
1.22
|
3.44e-03
|
GO:0006796
|
phosphate metabolic process
|
1.58
|
4.01e-03
|
GO:0001655
|
urogenital system development
|
1.14
|
4.23e-03
|
GO:0044249
|
cellular biosynthetic process
|
1.39
|
4.24e-03
|
GO:0001501
|
skeletal system development
|
1.61
|
4.30e-03
|
GO:0060537
|
muscle tissue development
|
1.47
|
4.42e-03
|
GO:0002009
|
morphogenesis of an epithelium
|
1.26
|
4.49e-03
|
GO:0006915
|
apoptosis
|
1.16
|
5.11e-03
|
GO:0007166
|
cell surface receptor linked signaling pathway
|
1.45
|
5.79e-03
|
GO:0003002
|
regionalization
|
1.14
|
7.35e-03
|
GO:0042221
|
response to chemical stimulus
|
1.21
|
8.17e-03
|
GO:0009605
|
response to external stimulus
|
1.56
|
8.42e-03
|
GO:0045165
|
cell fate commitment
|
1.71
|
8.47e-03
|
GO:0030326
|
embryonic limb morphogenesis
|
1.71
|
8.47e-03
|
GO:0035113
|
embryonic appendage morphogenesis
|
1.36
|
8.49e-03
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
1.83
|
8.86e-03
|
GO:0042326
|
negative regulation of phosphorylation
|
1.37
|
9.25e-03
|
GO:0045597
|
positive regulation of cell differentiation
|
1.41
|
1.04e-02
|
GO:0010608
|
posttranscriptional regulation of gene expression
|
1.16
|
1.04e-02
|
GO:0016070
|
RNA metabolic process
|
1.29
|
1.10e-02
|
GO:0051253
|
negative regulation of RNA metabolic process
|
1.61
|
1.10e-02
|
GO:0014706
|
striated muscle tissue development
|
1.29
|
1.12e-02
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
1.20
|
1.15e-02
|
GO:0051246
|
regulation of protein metabolic process
|
1.23
|
1.17e-02
|
GO:0016310
|
phosphorylation
|
1.37
|
1.39e-02
|
GO:0051093
|
negative regulation of developmental process
|
1.25
|
1.41e-02
|
GO:0012501
|
programmed cell death
|
1.27
|
1.42e-02
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.78
|
1.44e-02
|
GO:2000027
|
regulation of organ morphogenesis
|
1.14
|
1.47e-02
|
GO:0065008
|
regulation of biological quality
|
1.45
|
1.47e-02
|
GO:0048514
|
blood vessel morphogenesis
|
1.40
|
1.48e-02
|
GO:0061061
|
muscle structure development
|
1.27
|
1.58e-02
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.16
|
1.59e-02
|
GO:0009059
|
macromolecule biosynthetic process
|
1.16
|
1.73e-02
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.67
|
1.85e-02
|
GO:0003007
|
heart morphogenesis
|
1.63
|
1.87e-02
|
GO:0072001
|
renal system development
|
1.10
|
2.16e-02
|
GO:0051179
|
localization
|
1.33
|
2.31e-02
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.31
|
2.34e-02
|
GO:0032583
|
regulation of gene-specific transcription
|
1.25
|
2.39e-02
|
GO:0042325
|
regulation of phosphorylation
|
1.26
|
2.59e-02
|
GO:0001932
|
regulation of protein phosphorylation
|
1.77
|
2.60e-02
|
GO:0010563
|
negative regulation of phosphorus metabolic process
|
1.77
|
2.60e-02
|
GO:0045936
|
negative regulation of phosphate metabolic process
|
1.57
|
2.89e-02
|
GO:0048705
|
skeletal system morphogenesis
|
1.40
|
3.05e-02
|
GO:0045596
|
negative regulation of cell differentiation
|
1.71
|
3.37e-02
|
GO:0048706
|
embryonic skeletal system development
|
1.14
|
3.47e-02
|
GO:0043412
|
macromolecule modification
|
1.24
|
3.50e-02
|
GO:0019220
|
regulation of phosphate metabolic process
|
1.24
|
3.50e-02
|
GO:0051174
|
regulation of phosphorus metabolic process
|
1.57
|
3.50e-02
|
GO:0010639
|
negative regulation of organelle organization
|
1.41
|
4.45e-02
|
GO:0048568
|
embryonic organ development
|
1.19
|
4.64e-02
|
GO:0010941
|
regulation of cell death
|